Butyrylcholinesterase Is a Potential Biomarker for SIDS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
EBioMedicine 2022 May 06;[EPub Ahead of Print], CT Harrington, NA Hafid, KA WatersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.